XIENCE V demonstrated

Related by string. * Xience : XIENCE V Everolimus Eluting . XIENCE V drug eluting . XIENCE V PROMUS Stent . XIENCE V Stent System / vs . Vs . VD . VS : b v * . V CAST Music . Microsoft Hyper V . overturn Roe v. Wade / demon strated . demon strating . Demonstrating . demonstrating : demonstrating knives mops . demonstrated statistically significant . demonstrated clinically meaningful * *

Related by context. Frequent words. (Click for all words.) 68 XIENCE V vs. 67 repeat revascularization 66 ischemic cardiomyopathy 65 systemic embolism 65 target lesion revascularization 65 SPIRIT III 65 achieved statistical significance 64 CYPHER ® Stent 64 TAXUS Stent 63 TRITON TIMI 63 TAXUS 63 target vessel revascularization 63 active comparator 62 coronary revascularization 62 plus dexamethasone 62 confidence interval #.#-#.# 62 undergoing coronary artery 62 vertebral fracture 62 placebo controlled clinical 62 Thrombolysis 61 neoadjuvant 61 composite endpoint 61 ADHF 61 noninferiority 61 thromboembolic events 61 cerebrovascular events 61 myocardial infarction stroke 61 Secondary endpoints included 61 irbesartan 61 tolvaptan 60 mg QD 60 plus gemcitabine 60 myocardial infarction MI 60 Secondary endpoints include 60 prespecified 60 % CI #.#-#.# [007] 60 cardiovascular hospitalization 60 CYPHER R Stent 60 paclitaxel eluting stent 60 plus methotrexate 60 discontinuations due 60 TAXUS stent 60 statistically significant p = 60 annualized relapse 60 stroke myocardial infarction 60 cytogenetic response 60 plus prednisone 60 Percutaneous Coronary Intervention 60 stent restenosis 60 stable angina 60 atherothrombosis 59 Pivotal Phase 59 Arch Intern Med 59 PRECiSE 59 gout flares 59 NYHA Class III 59 chlorambucil 59 left ventricular dysfunction 59 Acute Myocardial Infarction 59 acute myocardial infarction AMI 59 CI -#.# 59 Combination therapy 59 complete cytogenetic 59 colorectal adenomas 59 evaluable 59 metastatic hormone refractory 59 infarct size 59 heavily pretreated 59 N Engl J 59 multicentre 59 J Am Coll 58 Amrubicin 58 secondary endpoint 58 myocardial infarctions 58 endarterectomy 58 fibrinolysis 58 ST elevation myocardial 58 mg kg dose 58 cardiovascular mortality 58 left ventricular systolic 58 elotuzumab 58 cystectomy 58 mediastinal 58 acute coronary syndromes ACS 58 inflammatory lesions 58 thromboembolism 58 cardiac dysfunction 58 TAXUS Express 58 severe renal impairment 58 liver transplant recipients 58 P = .# 58 Ischemic 58 NYHA class 58 eszopiclone 58 relapsed refractory multiple myeloma 58 febrile neutropenia 58 J Clin Oncol 58 nonsignificant 58 nab paclitaxel 58 non inferiority 58 thrombotic events

Back to home page